3 Einträge |
Seite 1 / 1
![]() |
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. |
Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F, Hammers H, Hutson TE, Lee JL, Peltola K, Roth BJ, Bjarnason GA, Géczi L, Keam B, Maroto P, Heng DY, Schmidinger M, Kantoff PW, Borgman-Hagey A, Hessel C, Scheffold C, Schwab GM, Tannir NM, Motzer RJ |
The New England journal of medicine. 2015 Sep 25. doi: 10.1056/NEJMoa1510016 |
PMID: 26406150 |
Randomized, double-blind, placebo-controlled, phase III study of bevacizumab with docetaxel or docetaxel with placebo as first-line therapy for patients with locally recurrent or metastatic breast cancer (mBC): AVADO. |
Miles D, Chan A, Romieu G, Dirix LY, Cortes J, Pivot X, Tomczak P, Taran T, Harbeck N, Steger GG |
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.lba1011 |
PMID: 27951290 |
ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students: 4 Years of Experience (2016-2019). |
Pavlidis N, Madry R, Peeters M, Sandrucci S, Markowska J, Peccatori F, Costa A, Eriksen JG, Ricardi U, Poetter R, Schrijvers D, Vermorken JB |
Journal of cancer education : the official journal of the American Association for Cancer Education. 2021 Jan 2. doi: 10.1007/s13187-020-01947-3. pii: 10.1007/s13187-020-01947-3 |
PMID: 33387267 |
3 Einträge |
Seite 1 / 1
![]() |